Adjuvant tamoxifen in postmenopausal women with high-risk breast cancer

Trial Profile

Adjuvant tamoxifen in postmenopausal women with high-risk breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2013

At a glance

  • Drugs Tamoxifen (Primary)
  • Indications Early breast cancer; Menopause
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
    • 13 Dec 2013 Primary endpoint 'Disease-free-survival' has been met.
    • 13 Dec 2013 Primary endpoint 'Death-rate' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top